Evogene annual free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evogene Free Cash Flow (FCF) History (EVGN)
Evogene reported −$13.6M in free cash flow for fiscal 2025, an increase of $6.7M from the previous fiscal year, with a free cash flow margin of −353.93%.
View full Evogene company overviewEvogene free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$13.6M | $6.7M | — | −353.93% |
| 2024 | 2024-12-31 | −$20.3M | $1.8M | — | −364.46% |
| 2023 | 2023-12-31 | −$22.2M | $2.7M | — | −742.92% |
| 2022 | 2022-12-31 | −$24.8M | $714,000 | — | −1483.52% |
| 2021 | 2021-12-31 | −$25.6M | −$5.4M | — | −2748.71% |
| 2020 | 2020-12-31 | −$20.2M | −$1.6M | — | −1941.92% |
| 2019 | 2019-12-31 | −$18.6M | −$3.0M | — | −2465.60% |
| 2018 | 2018-12-31 | −$15.5M | $984,000 | — | −889.24% |
| 2017 | 2017-12-31 | −$16.5M | −$4.0M | — | −488.58% |
| 2016 | 2016-12-31 | −$12.5M | $1.9M | — | −191.15% |
| 2015 | 2015-12-31 | −$14.4M | — | — | −129.50% |
Evogene quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Evogene free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$20.2M to −$13.6M, a net increase of $6.6M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Evogene filings at SEC.gov ↗